Compare ALNT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALNT | MDXG |
|---|---|---|
| Founded | 1962 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 1995 | 2007 |
| Metric | ALNT | MDXG |
|---|---|---|
| Price | $64.39 | $4.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $58.00 | $10.00 |
| AVG Volume (30 Days) | 146.8K | ★ 796.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | ★ 67.09 | 14.29 |
| EPS | ★ 1.32 | 0.32 |
| Revenue | ★ $554,478,000.00 | $418,630,000.00 |
| Revenue This Year | $5.57 | N/A |
| Revenue Next Year | $6.66 | $13.14 |
| P/E Ratio | $65.89 | ★ $14.88 |
| Revenue Growth | 4.62 | ★ 19.99 |
| 52 Week Low | $19.25 | $4.70 |
| 52 Week High | $70.00 | $8.20 |
| Indicator | ALNT | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 25.08 |
| Support Level | $43.04 | N/A |
| Resistance Level | $65.41 | $5.38 |
| Average True Range (ATR) | 3.59 | 0.19 |
| MACD | -0.65 | -0.02 |
| Stochastic Oscillator | 67.99 | 3.57 |
Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.